# Propranolol for Sleep Apnea Therapy

> **NCT03049306** · PHASE2 · COMPLETED · sponsor: **Johns Hopkins University** · enrollment: 24 (actual)

## Conditions studied

- Obstructive Sleep Apnea

## Interventions

- **DRUG:** Propranolol Oral Tablet
- **DRUG:** Placebo Oral Tablet

## Key facts

- **NCT ID:** NCT03049306
- **Lead sponsor:** Johns Hopkins University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-02-15
- **Primary completion:** 2024-05-01
- **Final completion:** 2024-05-01
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2024-09-05

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03049306

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03049306, "Propranolol for Sleep Apnea Therapy". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT03049306. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
